Skip to content
INDIASAY

Record view

Product type
api
Audit evidence
No audit report on record.
Record verified
21 August 2026
Official product photograph required — MSN Group, API manufacturing — DMF portfolio (not itemised per molecule)

Public Product Record

As published by the manufacturer
Specification
MSN Group's own regulatory page states an aggregate portfolio of 529 US DMFs, 181 EU DMFs and 160 CEPs across its API business as of the date accessed below. This is a company-level aggregate claim, not a per-molecule filing — no single molecule name or DMF number is asserted by this record.
Packing
Not published — quoted against your specification
MOQ
Not published — quoted against your specification
Lead time
Not published — quoted against your specification
HS code
Not published — quoted against your specification
Price
Not published — quoted against your specification

Regulatory record — Active Pharmaceutical Ingredient

Verified 21 August 2026
US DMF number
Not published
US DMF status
Not published
CEP status
Not published
Letter of Access
Not published
LoA turnaround
Not published
Last US FDA inspection
Not published
Inspection outcome
Not published
Pharmacopoeia
Not published
Capacity available now
Not published
US supply active
Not published
Backward integrated
Not published
Multi-site
Not published

Audit evidence

Licensed in from the accredited body named — never an Indiasay audit

No audit report on record.

Documentation available

Released against a named consignee
  • ·Certificate of analysis for the supplied lot
  • ·Specification sheet, countersigned
  • ·Packing list and lot coding
  • ·Origin declaration
  • ·Destination-market documentation per the category guide

Released against a named consignee. Held by the manufacturer, transmitted by Indiasay.